CN1511583A - Chinese rose extract and its preparing method and use - Google Patents
Chinese rose extract and its preparing method and use Download PDFInfo
- Publication number
- CN1511583A CN1511583A CNA2003101215799A CN200310121579A CN1511583A CN 1511583 A CN1511583 A CN 1511583A CN A2003101215799 A CNA2003101215799 A CN A2003101215799A CN 200310121579 A CN200310121579 A CN 200310121579A CN 1511583 A CN1511583 A CN 1511583A
- Authority
- CN
- China
- Prior art keywords
- extract
- water
- fols
- flos rosae
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 94
- 240000008254 Rosa chinensis Species 0.000 title claims abstract description 12
- 235000000664 Rosa chinensis Nutrition 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims description 32
- 239000003814 drug Substances 0.000 claims abstract description 52
- 239000008280 blood Substances 0.000 claims abstract description 50
- 210000004369 blood Anatomy 0.000 claims abstract description 50
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 230000001603 reducing effect Effects 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 95
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 91
- 241000628997 Flos Species 0.000 claims description 73
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 229940079593 drug Drugs 0.000 claims description 27
- 239000000706 filtrate Substances 0.000 claims description 23
- 239000012567 medical material Substances 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 16
- 229930003944 flavone Natural products 0.000 claims description 14
- 235000011949 flavones Nutrition 0.000 claims description 14
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 claims description 12
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- 150000002212 flavone derivatives Chemical class 0.000 claims description 12
- 239000003208 petroleum Substances 0.000 claims description 12
- 150000007965 phenolic acids Chemical class 0.000 claims description 12
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 150000004676 glycans Chemical class 0.000 claims description 10
- 229920001282 polysaccharide Polymers 0.000 claims description 10
- 239000005017 polysaccharide Substances 0.000 claims description 10
- 239000000469 ethanolic extract Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 7
- 239000007924 injection Substances 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 239000003456 ion exchange resin Substances 0.000 claims description 6
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 5
- 238000003809 water extraction Methods 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004952 Polyamide Substances 0.000 claims description 3
- 239000003463 adsorbent Substances 0.000 claims description 3
- 238000003810 ethyl acetate extraction Methods 0.000 claims description 3
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 2
- 230000036541 health Effects 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 23
- 238000002474 experimental method Methods 0.000 abstract description 13
- 241001465754 Metazoa Species 0.000 abstract description 11
- 239000000843 powder Substances 0.000 description 41
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 28
- 239000008103 glucose Substances 0.000 description 28
- 239000003153 chemical reaction reagent Substances 0.000 description 24
- 241000700159 Rattus Species 0.000 description 21
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 18
- 210000004153 islets of langerhan Anatomy 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 238000011161 development Methods 0.000 description 12
- 230000018109 developmental process Effects 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 10
- 238000004090 dissolution Methods 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 102000004877 Insulin Human genes 0.000 description 9
- 108090001061 Insulin Proteins 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229940125396 insulin Drugs 0.000 description 9
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 8
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 201000001421 hyperglycemia Diseases 0.000 description 7
- -1 smash to pieces Substances 0.000 description 7
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 238000010172 mouse model Methods 0.000 description 6
- 210000000496 pancreas Anatomy 0.000 description 6
- 238000007560 sedimentation technique Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 239000002024 ethyl acetate extract Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000002879 macerating effect Effects 0.000 description 4
- 229940000406 drug candidate Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002481 ethanol extraction Methods 0.000 description 3
- 239000003777 experimental drug Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000004279 orbit Anatomy 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229960004586 rosiglitazone Drugs 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LLJFMFZYVVLQKT-UHFFFAOYSA-N 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-2-isoquinolinyl)ethyl]phenyl]sulfonylurea Chemical compound C=1C(OC)=CC=C(C(C2=O)(C)C)C=1C(=O)N2CCC(C=C1)=CC=C1S(=O)(=O)NC(=O)NC1CCCCC1 LLJFMFZYVVLQKT-UHFFFAOYSA-N 0.000 description 2
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 2
- FOGVNFMUZXDMTR-UHFFFAOYSA-N [Mg].Cl Chemical compound [Mg].Cl FOGVNFMUZXDMTR-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229960003468 gliquidone Drugs 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229960001052 streptozocin Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 238000006424 Flood reaction Methods 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- SOSLMHZOJATCCP-AEIZVZFYSA-N afzelin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O SOSLMHZOJATCCP-AEIZVZFYSA-N 0.000 description 1
- SOSLMHZOJATCCP-PADPQNGGSA-N afzelin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)C1=C(c2ccc(O)cc2)Oc2c(c(O)cc(O)c2)C1=O SOSLMHZOJATCCP-PADPQNGGSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- NCZJHBOLUQWVQK-UHFFFAOYSA-N kaempferol 3-O-rhamnoside Natural products CC1OC(OC2=C(Oc3c(O)cc(O)cc3C2=O)c4ccc(O)cc4)C(O)C(O)C1O NCZJHBOLUQWVQK-UHFFFAOYSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 229940003509 rosiglitazone 4 mg Drugs 0.000 description 1
- 229960003271 rosiglitazone maleate Drugs 0.000 description 1
- SUFUKZSWUHZXAV-BTJKTKAUSA-N rosiglitazone maleate Chemical compound [H+].[H+].[O-]C(=O)\C=C/C([O-])=O.C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O SUFUKZSWUHZXAV-BTJKTKAUSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to Chinese rose extract, its preparation process and application in preparing medicine for treating diabetes. Animal experiment shows that Chinese rose extracts obtained via different extraction processes have obvious blood sugar reducing effect and may be used in preparing medicine for treating diabetes.
Description
Technical field
The present invention relates to Fols Rosae extract and extracting method thereof, and the application in preparation treatment diabetes medicament.
Background technology
Diabetes are a kind of common metabolic diseases, it is absolute or the imbalance of carbohydrate metabolism that relative hyposecretion caused by insulin, and then cause fat, protein metabolism disorder, therefore improve factors such as the unreasonable and gene of the dietary structure of bringing along with aging, the living standard of world population, diabetes have become a kind of commonly encountered diseases, frequently-occurring disease, because it relates to the whole body system, so that many fatefulue complication take place, human life and health in serious threat.
Generally diabetes can be divided into following several types: A, insulin-dependent (abbreviation type i diabetes); B, non-insulin-depending type (abbreviation type ii diabetes); C, malnutrition type diabetes; The diabetes of D, other types, wherein type ii diabetes accounts for more than 85% of diabetics total number of persons, and sickness rate sharply increases.
At present, oral antidiabetic drug commonly used both at home and abroad is of a great variety, mainly be sulfonylurea, biguanides, biological preparation alpha-glucosidase inhibitor and some Chinese medicine and western medicine compound preparations, although said medicine has certain therapeutical effect to each paradiabetes, but their common feature is that the medication cycle is long, improvement to symptom lacks positive effect, and " knock-on " phenomenon is in various degree all arranged after the drug withdrawal.
The Flos Rosae Chinensis nature and flavor are sweet, warm, have promoting blood flow to regulate menstruation, diffusing malicious detumescence effect, be mainly used in gynaecopathias such as treatment menoxenia, in Chinese patent 98100371.0 and 99103552.6,, be used for the treatment of diabetes with Flos Rosae Chinensis and other drug compatibility, but regrettably this Chinese prescription complexity, each component drug effect is indeterminate, and quality is wayward, is unfavorable for being prepared into pharmaceutical preparation.
In Xu Wenzhao is published in " research of the flavones ingredient of Flos Rosae Chinensis petal " literary composition on Nanjing University of Traditional Chinese Medicine's journal (natural science edition) the 16th the 4th phase of volume of July in 2000, the author is by carrying out ethanol extraction to Flos Rosae Chinensis, Sephadex LH20 column chromatography for separation, determine structure and measure general flavone content through wave spectrum analysis with HPLC, obtain four chemical compounds and be respectively quercitrin through identifying, kaempferol-3-O-rhamnoside, Quercetin and Rhizoma Kaempferiae flavin, each flavone component content is: 73.61%, 22.5%, 0.45%, 1.56%, although this paper analyzes the flavone component of Flos Rosae Chinensis petal, but its medical value is not proposed any suggestion, do not do deep research yet.
The applicant applied for " Fols Rosae extract and its production and use " on the 28th in December in 2002, the clear and definite pharmacological action of Fols Rosae extract, but the qualitative and more deep drug efficacy study of its extract is awaited to carry out.
Summary of the invention
Problem to be solved by this invention is by the preparation to Fols Rosae extract, extract is carried out qualitative investigation, carrying out seeking the clinical application of this extract on a large amount of effect experiment bases, and this extract is used for pharmaceutical preparation, obtain being suitable for the dosage form of clinical practice.
The present invention obtains Fols Rosae extract by the following method:
Water extraction: get the Flos Rosae Chinensis medical material, smash to pieces a little, extracting in water, merge extractive liquid, is concentrated into the extractum that every 1ml contains the 1g crude drug, promptly gets the water extract of Flos Rosae Chinensis, extracts temperature from 0-100 ℃.
Water was put forward the post method: get the water extract that above-mentioned water extraction obtains, cross detached dowel, water and alcohol or water and sour water be eluting successively, gets the total phenolic acid of Flos Rosae Chinensis.
When water extract passes through macroporous adsorbent resin, make water, alcohol eluting successively, collect the ethanol elution thing; When water extract passed through ion exchange resin column, water, diluted acid be eluting successively, collected the diluted acid eluent; Water extract is by polyamide column, and water, methanol-eluted fractions are collected meoh eluate.
Decoction and alcohol sedimentation technique: the Flos Rosae Chinensis defat with petroleum ether, medicinal residues volatilize petroleum ether, extract with above-mentioned water extraction, filter, and filtrate is condensed into the thick paste shape, precipitates with ethanol, standing over night, precipitation is got in centrifugal filtration, is drying to obtain the total polysaccharides of Flos Rosae Chinensis.
Alcohol extracting method: get the Flos Rosae Chinensis medical material, smash to pieces, extract with the lower alcohol of 30%-98%, temperature is from 0-90 ℃, extracting liquid filtering, and filtrate merges, and is concentrated into extractum, promptly gets the ethanol extract of Flos Rosae Chinensis.
Described lower alcohol comprises a kind of, the perhaps two or more mixed alcohol in methanol, ethanol, normal propyl alcohol, isopropyl alcohol, n-butyl alcohol, the isobutanol.
The alcohol extraction extraction: get the ethanol extract that above-mentioned alcohol extracting method obtains, behind the extractum water suspendible, use ethyl acetate extraction, combining extraction liquid is concentrated into thick paste, promptly gets Chinese rose total flavone.
Fols Rosae extract can be used as active component and the acceptable drug carrier is made application oral or injection folk prescription and compound preparation.
The Fols Rosae extract that obtains with said method is respectively Flos Rosae Chinensis water extract, the total phenolic acid of Flos Rosae Chinensis, Flos Rosae Chinensis total polysaccharides, Flos Rosae Chinensis ethanol extract or Chinese rose total flavone, has significant blood sugar reducing function by medical effect experiment shows.
The present invention passes through Fols Rosae extract in the research aspect the blood sugar lowering, provide a kind of hypoglycemic medicine safely and effectively for clinical, this rule of origin is in natural drug, compare with existing synthetic drug, have safe advantage, compare with existing Chinese patent medicine, it is little to have dosage, blood sugar reducing function is clear and definite, can be made into oral or advantage such as ejection preparation use.
The specific embodiment
The present invention with the optimal way of method for preparing Fols Rosae extract is:
The preferred water lifting manipulation: get the Flos Rosae Chinensis medical material, smash to pieces a little, extracting in water, extracting temperature is 10-100 ℃ of merge extractive liquid,, is concentrated into the extractum that every 1ml contains the 1g crude drug, promptly gets the water extract of Flos Rosae Chinensis.
Preferred water was put forward the post method: get the Flos Rosae Chinensis water extract that makes by the preferred water lifting manipulation, and behind 717 type strong base ion exchange resin, water, dilute hydrochloric acid eluting successively, collect the diluted acid eluent, being condensed into thick paste, being drying to obtain. a little uses water dissolution to get above-mentioned dry powder, adopts chemistry
Reagent color developing method carries out qualitative, and the result is as follows:
Testing reagent colour developing result
2%FeCL
3Bluish violet
1%FeCL
3/ 1%K
3Fe (CN)
6Navy blue
0.05% bromophenol blue yellow
0.1% bromocresol green yellow
Therefore this extract is defined as total phenolic acid.
Preferred decoction and alcohol sedimentation technique: Flos Rosae Chinensis defat with petroleum ether, medicinal residues volatilize petroleum ether, and extracting in water filters, filtrate is condensed into the thick paste shape, adding 95% ethanol makes and contains alcohol amount and reach 80%, standing over night, collecting precipitation, dry, promptly get the Flos Rosae Chinensis total polysaccharides, a little uses water dissolution to get above-mentioned dry powder, with following chemical analysis reagent following reaction is arranged:
Testing reagent measured object colour developing result
Alpha-Naphthol purple ring
The preferred alcohols lifting manipulation: get the Flos Rosae Chinensis medical material, smash to pieces a little, directly the ethanol with 60-95% concentration extracts, and temperature is controlled at 10-90 ℃, extracting liquid filtering, and filtrate merges, and is condensed into the extractum that 1ml contains the 1g crude drug, promptly gets the ethanol extract of Flos Rosae Chinensis.
Preferred alcohol extraction extraction: get Flos Rosae Chinensis 95% ethanol ethanol extract, behind the water suspendible, use ethyl acetate extraction, the combined ethyl acetate extract is concentrated into the thick paste shape, drying, a little uses dissolve with methanol to get dry powder, and it is qualitative to adopt the chemical reagent development process to carry out, and the result is as follows:
Testing reagent colour developing result
Hydrochloric acid-magnesium powder reaction foam redness
1% aluminum chloride/daylight yellow
1% aluminum chloride/UV yellow green
NH
3/ daylight buff
NH
3/ UV yellow green
1%Mg (OAC)
2/ UV yellow green
Therefore the Fols Rosae extract extract with the preparation of this kind method is defined as total flavones.
For describing the preparation and the blood sugar reducing function thereof of Fols Rosae extract among the present invention in detail, respectively by following examples explanation.
Embodiment one: the preparation of Flos Rosae Chinensis water extract (I)
Get Flos Rosae Chinensis medical material 1kg, smash to pieces a little, add 10 times of water gaging reflux, extract,, extract altogether 3 times, each 1 hour, merge extractive liquid, filtered, and filtrate is concentrated into the extractum that every 1ml contains the 1g crude drug, altogether the about 330g of extractum.
Embodiment two: the preparation of Flos Rosae Chinensis ethanol extraction (II)
Get Flos Rosae Chinensis medical material 1kg, smash to pieces a little, add 8 times of amount 45% alcohol and carry out the room temperature lixiviate, altogether lixiviate is 3 times, each 8 hours, merge lixiviating solution, filter, filtrate is concentrated into the extractum that every 1ml contains the 1g crude drug, altogether the about 150g of extractum.
Embodiment three: the preparation of Flos Rosae Chinensis ethanol extraction (II*)
Get Flos Rosae Chinensis medical material 1kg, smash to pieces a little, add 8 times of amount 60% ethanol and carry out reflux, extract,, extract altogether 3 times, each 1 hour, merge extractive liquid, filtered, and filtrate is concentrated into the extractum that every 1ml contains the 1g crude drug, altogether the about 200g of extractum.
Embodiment four: Fols Rosae extract (I), (II), (II*) are to the influence of experimental hyperglycemia model mice blood glucose
1 experiment purpose
Observe the influence of Fols Rosae extract, for the screening active drug provides foundation to experimental hyperglycemia model mice blood glucose.
2 experiment reagent:
Alloxan (Alloxan): SIGMA company, lot number: 2244-11-3; The blood sugar detection medicine box, Beijing Zhongsheng Biological Engineering High Technology Company, lot number: 000201
3 laboratory animals:
Kunming mouse: 23-28g, the male and female dual-purpose, Hebei province's Experimental Animal Center provides, the quality certification number: word 04035 is moved in the Ji
4 experimental techniques:
Get the Kunming mouse of body weight 23-28g, the male and female dual-purpose, fasting be can't help water after 24 hours, lumbar injection alloxan 200mg/kg, duplicate injection in second day once causes the experimental hyperglycemia model.Last injection alloxan is after 72 hours, and mouse orbit is got blood and surveyed blood glucose (the mice fasting be can't help water 14 hours before getting blood).Choose the mice of blood glucose 〉=10.0mmol/L, be divided into model group and Fols Rosae extract (I), (II), (II*) high and low dose group, every group of 14-18 only presses the 0.2ml/10g body weight and irritates stomach: 4g/kg, 8g/kg, and model group is given the equivalent distilled water.Once a day, continuous 14 days.The 15th day mouse orbit got blood and surveyed blood glucose (the mice fasting be can't help water 14 hours before getting blood).Calculate the mouse blood sugar average, with t check carrying out statistical analysis, relatively administration front and back and group difference.
5 experimental results:
Fols Rosae extract (I), (II), (II*) compare with model group under 4g/kg, 8g/kg dosage, can obviously reduce the blood glucose value of experimental hyperglycemia model mice; With the blood glucose value that relatively can obviously reduce the experimental hyperglycemia model mice before the administration.
Table 1: Fols Rosae extract (I), (II), (II*) are to the experimental hyperglycemia model mice
The influence of blood glucose (X=SD)
Group dosage blood glucose (mmol/L)
After the preceding administration of N (g/kg) administration
Model group 10 25.7 ± 5.34 31.42 ± 5.64
(I) 10 4.00 23.10±7.57 16.18±6.36
ΔΔ*
10 8.00 26.11±9.75 16.32±9.58
ΔΔ*
(II) 10 4.00 23.65±10.75 17.88±5.38
10 8.00 22.49±6.80 10.11±7.13
ΔΔ**
(II*) 10 4.00 21.23±0.39 18.06±4.66
Δ
10 8.00 24.43±10.64 14.78±3.22
ΔΔ*
Compare Δ: P＜0.01, Δ Δ: P＜0.001 with model group
With comparison *: P＜0.05 before the administration, * *: P＜0.01, * * *: P＜0.001
6 experiment conclusion: Flos Rosae Chinensis water extract (I), ethanol extract (II, II*) can obviously reduce the blood glucose value of experimental hyperglycemia model mice.
Embodiment five: the Flos Rosae Chinensis water extract is crossed the preparation (III) of anion-exchange resin column eluate
Get Flos Rosae Chinensis medical material 1kg, smash to pieces a little, add the lixiviate of 10 times of water gaging room temperatures, extract altogether 3 times, each 1 hour, merge extractive liquid, filtered, and filtrate is concentrated into the extractum that every 1ml contains the 1g crude drug, altogether the about 330g of extractum.With anion-exchange resin column on the extractum, water, diluted acid water elution get the partly about 100g of sour water eluting respectively.
Embodiment six: Fols Rosae extract (III) is to the influence of KKII type blood glucose in diabetic mice
1 experiment purpose
Observe behind Fols Rosae extract (III) oral administration influence to KKII type blood glucose in diabetic mice.
2 experiment materials:
2.1 tried thing and medicine
Fols Rosae extract (III) is brown extractum, and after grinding with a small amount of tween 80, adding distil water is mixed with 0.4g/ml, uses for the KK mouse stomach.
The rosiglitazone maleate sheet, Smithkline Beecham (Tianjin) company limited production, every contains rosiglitazone 4mg, with preceding tablet is ground, and the suspension that is mixed with 0.025mg/ml with distilled water is used for the KK mouse stomach.
2.2 animal
KK/Upj-Ay/JII type diabetic mice, Chinese Academy of Medical Sciences's laboratory animal provides, secondary animal, the animal quality certification number: SGKK II-00-0006.Animal feeding is in the observation ward that free key control is arranged, and room temperature is 24 ± 2 ℃, raises with the high-fat feedstuff (feed nutrition department of laboratory animal institute of the Chinese Academy of Medical Sciences provides) that brings out, freely drink water (tap water that contains 0.16% hydrochloric acid, PH9.3).
2.3 instrument
GT-1640 capital of a country blood glucose meter, Japanese ARKRAY, Inc. product.
3 test methods
32 of KKII type diabetic mices, body weight 41.4 ± 7.4g, the male and female dual-purpose, after water 2h is can't help in the animal fasting, the tail vein is got the about 10ml of blood, measures its blood glucose value with GT-1640 capital of a country blood glucose meter, chooses the mice of blood glucose value 〉=8.0nmol/L, be divided into 4 groups by blood glucose value and body weight stratified random, every group 8, the solvent control group contains the distilled water of 1% tween 80, and Fols Rosae extract (III) give corresponding medicinal liquid, dosage is 8g crude drug/kg, the positive drug group gives rosiglitazone, and dosage is 0.5mg/kg, and the administration volume is 0.2ml/10g, every day 1 time, continuous 15 days, respectively at the 5th, 10,1h measures blood glucose value (fasting be can't help water 2 hours) after the administration in 15 days, calculates the average of respectively organizing the mouse blood sugar value, adopt paired t-test to carry out statistical procedures, relatively before the administration, the diversity of back mean.
4 result of the tests
Behind KKII type diabetic mice orally give Fols Rosae extract (III), the rosiglitazone, its blood glucose all has significant reduction.
Table 2 Fols Rosae extract (III) is to the blood sugar influence of diabetic mice
Group dosage blood glucose value (mmol/L)
(behind the administration prodrug of g crude drug/kg/d) behind the 5th day medicine behind the 10th day medicine the 15th day
Solvent control
11.7±2.9 11.6±3.1 11.6±3.1 11.9±2.8
-0.09±2.43 -0.10±2.20 0.24±1.52
(III) 8 11.8±3.3 8.8±2.3
** 8.2±2.5
*** 8.5±1.8
***
-3.00±2.31 -3.59±1.86 -3.28±1.71
Rosiglitazone 0.5mg/kg/d 11.9 ± 2.5 8.5 ± 3.0
*8.1 ± 2.1
*7.1 ± 2.0
* *
-3.44±2.41 -3.85±2.20 -4.80±1.91
With comparison before the administration, * P＜0.05, * * P＜0.01, * * * P＜0.001
5 conclusions
The above results shows that Fols Rosae extract (III) has significant blood sugar reducing function.
Embodiment seven: the preparation of alcohol extracting method Chinese rose total flavone C
Flos Rosae Chinensis medical material 1kg smashs to pieces a little, floods under room temperature with 10 times of amount 95% ethanol, and lixiviate is three times altogether, each 24 hours, to filter, filtrate merges, reclaim ethanol to do not have alcohol distinguish the flavor of extractum, ethyl acetate repeatedly extracts behind the extractum water suspendible, up to the extract color light or several colourless to the greatest extent till.The combined ethyl acetate extract is concentrated into the thick paste shape, drying.Altogether the about 70g of dry powder.
A little uses dissolve with methanol to get above-mentioned dry powder, with the chemical reagent development process this dry powder is carried out qualitatively, and the result is as follows:
Colour reagent/condition colour developing result
Hydrochloric acid-magnesium powder reaction foam redness
1% aluminum chloride/daylight yellow
1% aluminum chloride/UV yellow green
NH
3/ daylight buff
NH
3/ UV yellow green
1%Mg (OAC)
2/ UV yellow green
Above-mentioned reaction is the Flavonoid substances qualitative reaction, so gained dry powder is Chinese rose total flavone.
Embodiment eight: water was proposed the preparation of the total phenolic acid D of post method Flos Rosae Chinensis
Get Flos Rosae Chinensis medical material 1kg, add the lixiviate three times under room temperature of 8 times of water gagings, each 24 hours, to filter, filtrate is by 717 type basic ion exchange resin columns, and water, 0.2N hydrochloric acid eluting are collected the sour water eluent and are concentrated into the thick paste shape successively, dry the about 40g of dry powder.
A little uses water dissolution to get above-mentioned dry powder, and it is qualitative to adopt the chemical reagent development process that this dry powder is carried out, and the result is as follows:
Colour reagent/condition colour developing result
2%FeCL
3Bluish violet
1%FeCL
3/ 1%K
3Fe (CN)
6Navy blue
0.05% bromophenol blue yellow
0.1% bromocresol green yellow
Above-mentioned reaction is phenolic hydroxyl group or carboxyl material qualitative reaction, so gained dry powder is the total phenolic acid of Flos Rosae Chinensis.
Embodiment nine: the preparation of decoction and alcohol sedimentation technique Flos Rosae Chinensis total polysaccharides E
Flos Rosae Chinensis medical material 1kg measures petroleum ether (60-90 ℃) reflux, extract, three times with 8 times, each 1 hour, medicinal residues volatilized petroleum ether. add 10 times of water gaging reflux, extract, twice, each 1 hour, filter, merging filtrate, being concentrated into relative density is the clear paste of 1.10 (50 ℃), adds 95% ethanol and makes and contain alcohol amount and reach 80%, standing over night, centrifugal filtration, collecting precipitation, the dry about 120g of dry powder that gets.
A little uses water dissolution to get above-mentioned dry powder, and it is qualitative to adopt the chemical reagent development process that this dry powder is carried out, and the result is as follows:
Testing reagent colour developing result
Alpha-Naphthol purple ring
Decoction and alcohol sedimentation technique is the saccharoidal extracting method of most plants, and above-mentioned reaction is the polysaccharose substance qualitative reaction, so gained dry powder is the Flos Rosae Chinensis total polysaccharides.
Embodiment ten: Chinese rose total flavone C, total phenolic acid D, total polysaccharides E pharmacological evaluation
1. experiment material and method:
1.1 main reagent and equipment:
Streptozotocin (STZ): SIGMA company provides, lot number: 112K1006;
Sodium citrate: factory provides by the Shenyang chemical reagent, lot number: 2000040;
Insulin test kit: provide lot number by U.S. Market company: 50920601.
Blood glucose test kit: Great Wall, Baoding clinical reagent company limited
Nikon ALPHAPHOT-2 YS2s type biological microscope
1.2 experimental drug product:
Flos Rosae Chinensis respectively extracts part: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. provides.
Gliquidone: German Green's lattice writing brush, Beijing ten thousand brightness drugmakers provide.
1.3 laboratory animal:
Body weight is 236 of the Wistar rats of 170+15g, and male and female half and half are provided by Chinese Medical Sciences University's Experimental Animal Center.
1.4 experimental technique:
Get body weight and be 236 of the Wistar rats of 170 ± 15g, wherein 10 normal test group of conduct.All the other rat disposable celiac injection streptozotocin (STZ), dosage is that (streptozotocin faces the solution that is mixed with 1% concentration with the aseptic sodium citrate buffer solution of preceding usefulness to 65mg/kg, PH=4.3).Lumbar injection streptozotocin (STZ) back the first two day rat should give the sucrose solution of 10% concentration, to prevent the death of rat hypoglycemia.Rat blood sugar is measured in one week back, get blood glucose value greater than 16.7mmol/L person as the diabetes model animal, the record blood glucose value.
Adopt Qu Zufa to be divided into 11 groups at random, every group 7 (wherein model group is 8), (high dose group is 20g crude drug/kg, middle dosage group 10g crude drug/kg, low dose group 5g crude drug/kg) to be respectively model group, positive drug group (gliquidone), C, D, the high, medium and low dosage group of E component.Positive drug and experimental drug are mixed with suspension, gastric infusion with 0.1% CMC sodium solution respectively.Model group gives CMC sodium solution.Normal group gives the tap water of equivalent.Get blood respectively at 7 days, 14 days eye sockets after the administration, measure rat blood sugar value and insulin level.Experiment finishes the back according to survey blood glucose, insulin value, gets the most significantly pancreatic tissue of rats in test groups of curative effect, fixes with 10% formalin solution, and islets of langerhans pathological change situation is observed in conventional H E dyeing.
2. experimental result
2.1. each medicine sees Table I to the influence of blood glucose in diabetic rats
In the C of the Chinese medicine ND-YJH group, low dose group compared significant difference (P＜0.05) with model group, the high low dose group of D component has been compared significant differences (P＜0.01) with model group, in the dosage group with compared significant difference (P＜0.05) with model group, in the E component, low dose group compared significant difference (P＜0.05) with model group, show that each extract of Flos Rosae Chinensis has the effect of the blood sugar level of the hyperglycemic rat that tangible reduction streptozotocin (STZ) caused.
Table I: each medicine is to the influence of blood glucose in diabetic rats
After the sample number administration after the administration in 7 days 14 days
Before the dosed administration
(n) X±SD(2h) X±SD(5h) X±SD(2h) X±SD(5h)
Negative group distilled water 10
Model group 0.1%CMC liquid 7 27.32 ± 6.22 23.73 ± 4.74 23.57 ± 6.00 26.41 ± 4.80 27.17 ± 6.08
Positive group 8 25.61 ± 6.17 17.56 ± 8.44 15.24 ± 8.31*, 18.17 ± 10.37*, 16.67 ± 11.17*
H(20g/kg) 7 25.66±6.03 18.64±7.82 13.99±7.09** 18.84±9.61 17.79±9.70*
C M(10g/kg) 7 24.63±7.09 15.03±8.80* 13.10±8.46* 23.89±8.93 17.24±9.85*
L(5g/kg) 7 26.64±7.45 14.83±11.07* 13.81±9.23* 15.26±10.57* 14.10±10.44**
H(20g/kg) 7 2751±6.65 18.39±9.23 10.09±7.70** 9.81±9.68** 10.70+10.33**
D M(10g/kg) 7 24.11±6.36 14.456+11.72* 12.43±9.64* 16.47±12.93* 17.13±8.56*
L(5g/kg) 7 24.94±7.93 14.80±6.81** 12.99±6.00** 19.45±6.11* 18.77±6.98*
H(20g/kg) 7 26.37±5.42 25.56±5.91 21.29±7.50 23.66±9.45 25.64±9.68
E M(10g/kg) 7 24.88±5.38 17.089±7.00* 15.79±6.61* 18.66±9.01* 19.63±9.62
L(5g/kg) 7 24.54±8.01 14.57±6.94* 14.63±8.21* 20.74±8.08 18.57±9.30*
Compare with model group: * P＜0.05, * * P＜0.01.
2.2. each medicine sees Table II to the influence of diabetes rat insulin level
In the C component of Chinese medicine ND-YJH, low dose group compared significant differences (P＜0.01) with model group, its high dose group and model group have significant difference (P＜0.05), the high and low dose group of D component has been compared significant differences (P＜0.01) with model group, wherein dosage group and model group have significant difference (P＜0.05).Illustrate that Chinese medicine ND-YJH has the effect of short diabetes rat excreting insulin.The E component does not have the effect of insulin secretion accelerating simultaneously, but can reduce rat blood sugar, illustrates that it reduces blood glucose in diabetic rats and realizes by other approach.
Table II: each medicine is to the influence of diabetes rat insulin level
After the sample number administration after the administration in 7 days 14 days
Dosage
(n) X±SD(2h) X±SD(2h)
Negative group distilled water 9 0.4243 ± 0.0673** 0.4102 ± 0.0512**
Model group 0.1%CMC liquid 6 0.5438+0.0759 0.5485 ± 0.0739
Positive group 6 0.4253+0.0656* 0.4248 ± 0.0655**
H(20g/kg) 6 0.4428+0.0550* 0.4548+0.0522
C M(10g/kg) 7 0.4451+0.0262* 0.4508+0.0269*
L(5g/kg) 6 0.4268±0.0317** 0.4323+0.0318**
H(20g/kg) 7 0.4025±0.0219** 0.4083±0.0218**
D M(10g/kg) 7 0.4730+0.0632 0.4597+0.0397*
L(5g/kg) 6 0.4275±0.0309** 0.4377±0.0310**
H(20g/kg) 7 0.4946+0.0642 0.5280+0.1481
E M(10g/kg) 6 0.5098+0.0982 0.5028+0.0908
L(5g/kg) 6 0.5173+0.0774 0.6065+0.0903
Compare with model group: * P＜0.05, * * P＜0.01.
2.3. respectively test the influence of medicine to diabetes rat pancreas pathological change.
Curative effect by the C of blood glucose and the visible experimental drug of insulin assay result, D extract part is clear and definite, so two groups of C, D, positive drug group and normal group are carried out pathology detection.Show that by pathological section islet cells is abundant in the islets of langerhans One's name is legion in the normal rats pancreas, islets of langerhans, queueing discipline.Islets of langerhans quantity reduces in the model group pancreas in rat, and the islet cells number also obviously reduces, and this is that (STZ0 can destroy islet cells in the pancreas in rat owing to streptozotocin.Islets of langerhans number in the positive drug group pancreas in rat is compared with normal rats also and is obviously reduced, and islet cells quantity also significantly reduces in the islets of langerhans, irregular arrangement.Islets of langerhans number in the C of experiment medicine group, the pancreas of D extraction unit hyte is compared with normal group also with the islet cells situation and is obviously reduced, and comparing with the positive drug group does not have tangible difference.
3. sum up
The C of Chinese medicine ND-YJH, D, E component have the obvious functions of blood sugar effect, and have the effect of insulin secretion accelerating.The rat Langerhans islet that this Chinese medicine causes streptozotocin (STZ) and the damage of islet cells are not seen and are improved significantly.
Embodiment 11: the preparation of Flos Rosae Chinensis water extract
Get Flos Rosae Chinensis medical material 1kg, smash to pieces a little, add 60 ℃ of warm macerating of 10 times of water gagings, altogether lixiviate is 3 times, and each 4 hours, merge extractive liquid, filtered, and filtrate is concentrated into the extractum that every 1ml contains the 1g crude drug, altogether the about 295g of extractum.
Embodiment 12: the preparation of Flos Rosae Chinensis water extract
Get Flos Rosae Chinensis medical material 1kg, smash to pieces a little, add 10 times of water gagings and carry out merceration under room temperature, altogether lixiviate is 3 times, and each 12 hours, merge extractive liquid, filtered, and filtrate is concentrated into the extractum that every 1ml contains the 1g crude drug, altogether the about 254g of extractum.
Embodiment 13: alcohol extracting method prepares Chinese rose total flavone
Flos Rosae Chinensis medical material 1kg smashs to pieces a little, and in 60 ℃ of warm macerating, lixiviate is three times altogether with 10 times of amount 95% ethanol, and each 8 hours, filtration, filtrate recycling ethanol gets extractum to there not being the alcohol flavor, repeatedly extracts with ethyl acetate behind the extractum water suspendible, and is colourless up to extract.The combined ethyl acetate extract is concentrated into the thick paste shape, drying.Altogether dry powder 85g.
A little uses dissolve with methanol to get above-mentioned dry powder, with the chemical reagent development process this dry powder is carried out qualitative, the colour developing result with embodiment seven.
Embodiment 14: alcohol extracting method prepares Chinese rose total flavone
Flos Rosae Chinensis medical material 1kg smashs to pieces a little, with 10 times of amount 95% alcohol reflux, extracts altogether three times, and each 2 hours, filtration, filtrate recycling ethanol gets extractum to there not being the alcohol flavor, repeatedly extracts with ethyl acetate behind the extractum water suspendible, and is colourless up to extract.The combined ethyl acetate extract is concentrated into the thick paste shape, drying.Altogether dry powder 102g.
A little uses dissolve with methanol to get above-mentioned dry powder, with the chemical reagent development process this dry powder is carried out qualitative, the colour developing result with embodiment seven.
Embodiment 15: water was put forward the post legal system and was equipped with the total phenolic acid of Flos Rosae Chinensis
Get Flos Rosae Chinensis medical material 1kg, in 60 ℃ of warm macerating, lixiviate is three times altogether with 8 times of water gagings, and each 8 hours, filter, merging filtrate is by 717 type strong alkali ion exchange resin posts, and water, 0.2N hydrochloric acid eluting are collected the hydrochloric acid eluent respectively, are condensed into thick paste, drying.Altogether dry powder 51g.
A little uses water dissolution to get above-mentioned dry powder, with the chemical reagent development process this dry powder is carried out qualitative, the colour developing result with embodiment eight.
Embodiment 16: water was put forward the post legal system and was equipped with the total phenolic acid of Flos Rosae Chinensis
Get Flos Rosae Chinensis medical material 1kg,, extract altogether three times with 8 times of water gaging reflux, extract,, each 1 hour, filter, merging filtrate is by 717 type strong alkali ion exchange resin posts, and water, 0.2N hydrochloric acid eluting are collected the hydrochloric acid eluent respectively, are condensed into thick paste, drying.Altogether dry powder 57g.
A little uses water dissolution to get above-mentioned dry powder, with the chemical reagent development process this dry powder is carried out qualitative, the colour developing result with embodiment eight.
Embodiment 17: water was put forward the post legal system and was equipped with the total phenolic acid of Flos Rosae Chinensis
Get Flos Rosae Chinensis medical material 1kg, with the lixiviate three times under room temperature of 8 times of water gagings, each 24 hours, filter, merging filtrate is by macroporous adsorbent resin S-8, and water, 50% ethanol and 95% ethanol elution are collected 50% ethanol elution respectively, are condensed into the thick paste shape, drying.Altogether dry powder 30g..
A little uses water dissolution to get above-mentioned dry powder, with the chemical reagent development process this dry powder is carried out qualitative, the colour developing result with embodiment eight.
Embodiment 18: water was put forward the post legal system and was equipped with the total phenolic acid of Flos Rosae Chinensis
Get Flos Rosae Chinensis medical material 1kg, with the lixiviate three times under room temperature of 8 times of water gagings, each 24 hours, filter, merging filtrate is by polyamide column, and water, 30% methanol, 50% methanol and methanol-eluted fractions are collected 30% meoh eluate respectively, are condensed into the thick paste shape, drying.Altogether dry powder 27g.
A little uses water dissolution to get above-mentioned dry powder, with the chemical reagent development process this dry powder is carried out qualitative, the colour developing result with embodiment eight.
Embodiment 19: decoction and alcohol sedimentation technique prepares the Flos Rosae Chinensis total polysaccharides
Flos Rosae Chinensis medical material 1kg measures petroleum ether (60-90 ℃) reflux, extract, three times with 8 times, each 1 hour, medicinal residues volatilized petroleum ether, added 10 times of water gagings and soaked under room temperature, lixiviate is three times altogether, each 24 hours, to filter, filtrate is condensed into the clear paste that relative density is 1.10 (50 ℃), adding 95% ethanol makes and contains alcohol amount and reach 80%, standing over night, collecting precipitation, the dry dry powder 105g that gets.
A little uses water dissolution to get above-mentioned dry powder, with the chemical reagent development process this dry powder is carried out qualitative, the colour developing result with embodiment nine.
Embodiment 20: decoction and alcohol sedimentation technique prepares the Flos Rosae Chinensis total polysaccharides
Flos Rosae Chinensis medical material 1kg measures petroleum ether (60-90 ℃) reflux, extract, three times with 8 times, each 1 hour, medicinal residues volatilized petroleum ether, added 10 times of water gagings and carried out warm macerating in 60 ℃, lixiviate is three times altogether, each 8 hours, to filter, filtrate is condensed into the clear paste that relative density is 1.10 (50 ℃), adding 95% ethanol makes and contains alcohol amount and reach 80%, standing over night, collecting precipitation, the dry dry powder 117g that gets.
A little uses water dissolution to get above-mentioned dry powder, with the chemical reagent development process this dry powder is carried out qualitative, the colour developing result with embodiment nine.
Claims (13)
1, a kind of Fols Rosae extract is characterized in that water extraction obtains Fols Rosae extract, gets the Flos Rosae Chinensis medical material, smash to pieces a little, and extracting in water, merge extractive liquid, is concentrated into the extractum that every 1ml contains the 1g crude drug, promptly gets the water extract of Flos Rosae Chinensis, extracts temperature from 0～100 ℃.
2, Fols Rosae extract according to claim 1 is characterized in that extracting preferred 10～100 ℃ of temperature, gets the Flos Rosae Chinensis water extract.
3, Fols Rosae extract according to claim 1 is characterized in that the Flos Rosae Chinensis extracting solution is crossed detached dowel, and water and alcohol or water and sour water be eluting successively, gets the total phenolic acid of Flos Rosae Chinensis.
4, Fols Rosae extract according to claim 3 when it is characterized in that water was carried post method water extract by macroporous adsorbent resin, makes water, alcohol eluting successively, collects the ethanol elution thing.
5, Fols Rosae extract according to claim 3, when it is characterized in that water extract passes through ion exchange resin column, water, diluted acid be eluting successively, collects the diluted acid eluent.
6, Fols Rosae extract according to claim 3 is characterized in that water extract passes through polyamide column, and water, methanol is eluting successively, collects meoh eluate.
7, Fols Rosae extract according to claim 1, it is characterized in that the Flos Rosae Chinensis defat with petroleum ether, medicinal residues volatilize petroleum ether, extract with above-mentioned water extraction, filter, filtrate is condensed into the thick paste shape, precipitate standing over night, centrifugal filtration with ethanol, get precipitation, be drying to obtain the total polysaccharides of Flos Rosae Chinensis.
8, a kind of Fols Rosae extract is characterized in that alcohol extracting method obtains Fols Rosae extract, gets the Flos Rosae Chinensis medical material, smashs to pieces, lower alcohol with 30%～98% extracts, and temperature is from 0～90 ℃, extracting liquid filtering, filtrate merges, and is concentrated into extractum, promptly gets the ethanol extract of Flos Rosae Chinensis.
9, Fols Rosae extract according to claim 8 is characterized in that described lower alcohol comprises a kind of, the perhaps two or more mixed alcohol in methanol, ethanol, normal propyl alcohol, isopropyl alcohol, n-butyl alcohol, the isobutanol.
10, Fols Rosae extract according to claim 8 is characterized in that getting the ethanol extract that above-mentioned alcohol extracting method obtains, and behind the extractum water suspendible, uses ethyl acetate extraction, and combining extraction liquid is concentrated into thick paste, promptly gets Chinese rose total flavone.
11, a kind of purposes of Fols Rosae extract is characterized in that the application in hypoglycemic medicine and blood sugar reducing health product thereof.
12, the purposes of Fols Rosae extract according to claim 11 is characterized in that Fols Rosae extract can be Flos Rosae Chinensis water extract, the total phenolic acid of Flos Rosae Chinensis, Flos Rosae Chinensis total polysaccharides, Flos Rosae Chinensis ethanol extract or Chinese rose total flavone and the two above combination arbitrarily.
13, a kind of purposes of Fols Rosae extract is characterized in that making application oral or injection folk prescription and compound preparation as active component and acceptable drug carrier.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101215799A CN1262273C (en) | 2002-12-28 | 2003-12-25 | Chinese rose extract and its preparing method and use |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN02160183.6 | 2002-12-28 | ||
| CN02160183 | 2002-12-28 | ||
| CNB2003101215799A CN1262273C (en) | 2002-12-28 | 2003-12-25 | Chinese rose extract and its preparing method and use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101139883A Division CN100337623C (en) | 2003-12-25 | 2003-12-25 | Chinese rose total flavone and its prepn and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1511583A true CN1511583A (en) | 2004-07-14 |
| CN1262273C CN1262273C (en) | 2006-07-05 |
Family
ID=34276132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2003101215799A Expired - Fee Related CN1262273C (en) | 2002-12-28 | 2003-12-25 | Chinese rose extract and its preparing method and use |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1262273C (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102920753A (en) * | 2012-11-05 | 2013-02-13 | 江苏省中国科学院植物研究所 | Dichromatism gmelin sealavender herb extractive and application thereof |
| CN102949306A (en) * | 2012-06-29 | 2013-03-06 | 上海莱博生物科技有限公司 | Extractive of flowers as well as preparation method and application thereof |
| CN106177035A (en) * | 2016-08-27 | 2016-12-07 | 贾陆 | There is blood sugar lowering, the preparation method and application of anticancer Flos Rosae Chinensis effective extract |
| CN106726868A (en) * | 2016-11-22 | 2017-05-31 | 厦门上新日用化学制品有限公司 | A kind of preparation method of the China rose anthocyanidin for having whitening capability |
| CN109956984A (en) * | 2019-04-23 | 2019-07-02 | 河南大学 | Extraction and separation method of pyrotechnic glycosides in Chinese rose |
| CN110003293A (en) * | 2019-04-23 | 2019-07-12 | 河南大学 | A method of extracting auicularin from China rose |
| CN110201044A (en) * | 2019-07-16 | 2019-09-06 | 上海晟薇生物科技有限公司 | Chinese rose extract, containing its product and its preparation method and application |
| CN111187365A (en) * | 2020-02-10 | 2020-05-22 | 河南大学 | Chinese rose polysaccharide, extraction method and application thereof in preparation of anticoagulant drugs |
| CN114720587A (en) * | 2022-03-09 | 2022-07-08 | 石家庄以岭药业股份有限公司 | Preparation method and characteristic map of Chinese rose preparation |
-
2003
- 2003-12-25 CN CNB2003101215799A patent/CN1262273C/en not_active Expired - Fee Related
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102949306A (en) * | 2012-06-29 | 2013-03-06 | 上海莱博生物科技有限公司 | Extractive of flowers as well as preparation method and application thereof |
| CN102949306B (en) * | 2012-06-29 | 2014-08-06 | 上海莱博生物科技有限公司 | Extractive of flowers as well as preparation method and application thereof |
| CN102920753A (en) * | 2012-11-05 | 2013-02-13 | 江苏省中国科学院植物研究所 | Dichromatism gmelin sealavender herb extractive and application thereof |
| CN106177035B (en) * | 2016-08-27 | 2020-03-03 | 贾陆 | Preparation method and application of effective rosa chinensis flower extract with blood sugar reducing and anticancer functions |
| CN106177035A (en) * | 2016-08-27 | 2016-12-07 | 贾陆 | There is blood sugar lowering, the preparation method and application of anticancer Flos Rosae Chinensis effective extract |
| CN106726868A (en) * | 2016-11-22 | 2017-05-31 | 厦门上新日用化学制品有限公司 | A kind of preparation method of the China rose anthocyanidin for having whitening capability |
| CN106726868B (en) * | 2016-11-22 | 2019-10-29 | 厦门上新日用化学制品有限公司 | A kind of preparation method for the China rose anthocyanidin having whitening capability |
| CN109956984A (en) * | 2019-04-23 | 2019-07-02 | 河南大学 | Extraction and separation method of pyrotechnic glycosides in Chinese rose |
| CN110003293A (en) * | 2019-04-23 | 2019-07-12 | 河南大学 | A method of extracting auicularin from China rose |
| CN110003293B (en) * | 2019-04-23 | 2022-01-28 | 河南大学 | Method for extracting parasitoside from Chinese rose |
| CN110201044A (en) * | 2019-07-16 | 2019-09-06 | 上海晟薇生物科技有限公司 | Chinese rose extract, containing its product and its preparation method and application |
| CN111187365A (en) * | 2020-02-10 | 2020-05-22 | 河南大学 | Chinese rose polysaccharide, extraction method and application thereof in preparation of anticoagulant drugs |
| CN114720587A (en) * | 2022-03-09 | 2022-07-08 | 石家庄以岭药业股份有限公司 | Preparation method and characteristic map of Chinese rose preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1262273C (en) | 2006-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101040915A (en) | Method for preparing a Shuanhuanglian injection and the component detecting method | |
| CN1233387C (en) | Chinese compound medicine for treating anhypnosis and its preparation metod | |
| CN1511583A (en) | Chinese rose extract and its preparing method and use | |
| CN1239183C (en) | A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof | |
| CN1843425A (en) | Dispersion tablet for getting brain and heart unobstructed and preparation method and its quality control method | |
| CN1220518C (en) | Chinese medicinal composition for anti-cancer and analgesia, its preparation method and its application in the preparation of product and medicine for treating cancer and analgesia | |
| CN1839932A (en) | Red sage root formulation for venous injection and preparation process thereof | |
| CN101028320A (en) | Vegetable medicinal composition with hypoglycemic and hypolipidemic functions and its making method | |
| CN1831015A (en) | Process for extracting fructus ligustri lucidi and Radixa stragali polysaccharide, the products and application thereof | |
| CN100337623C (en) | Chinese rose total flavone and its prepn and use | |
| CN1679648A (en) | Mailuoning injection and its preparation and quality control | |
| CN1634463A (en) | Medicine for treating diabetes and production method thereof | |
| CN1300161C (en) | Yellow pigment of safflower preparation method and application | |
| CN1569119A (en) | Dogwood extraction and its preparation method and usage | |
| CN1194743C (en) | Chinese medicinal composition for treating atrophic arthritis, preparing method and quality controlling method thereof | |
| CN1569867A (en) | Preparation method and use of skunk bush extract morroniside | |
| CN1285358C (en) | Medicinal composition, preparation and quality control thereof | |
| CN1569205A (en) | Method for preparing and controlling the quality of Chinese medicinal soft capsule | |
| CN1843442A (en) | Oral disintegration tablet of 'Huo Xiang Zheng Qi' and preparation method and quality control method | |
| CN1210048C (en) | Gingko leaf drop pill | |
| CN1686317A (en) | Ginkgo total lactone composition possessing nervo protection action | |
| CN1303980C (en) | Orally quick releasing tablet of compound red sage root, its medical uses and preparation process | |
| CN1594246A (en) | Rhizoma Anemarrhenae total phenol extract, its preparation method and application | |
| CN1733089A (en) | Medicine for treating diabetes and its complications and process for preparing the same | |
| CN1626103A (en) | Combination of medication of containing general saponin of notoginseng and icariin as well as usage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Succession or assignment of patent right |
Owner name: ZHONGQI PHARMACEUTICAL TECHNOLOGY( SHIJIAZHUANG ) Free format text: FORMER OWNER: PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD., SHIJIAZHUANG PHARMACEUTICAL GRO Effective date: 20040604 |
|
| C06 | Publication | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| PB01 | Publication | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20040604 Address after: No. 276, Zhongshan West Road, Hebei, Shijiazhuang Applicant after: SHIJIAZHUANG PHARMA. GROUP ZHONGQI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) Co.,Ltd. Address before: No. 276, Zhongshan West Road, Hebei, Shijiazhuang Applicant before: Pharmaceutical Technology Development Co., Ltd., Shijiazhuang Pharmaceutical Gro |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: CSPC YINHU PHARMACEUTICAL CO., LTD. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20101019 Address after: 050051 No. 276 West Zhongshan Road, Hebei, Shijiazhuang Co-patentee after: CYPC Yinhu Pharmaceutical Co., Ltd. Patentee after: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. of CSPC Group Address before: 050051 No. 276 West Zhongshan Road, Hebei, Shijiazhuang Patentee before: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. of CSPC Group |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060705 Termination date: 20141225 |
|
| EXPY | Termination of patent right or utility model |